🇺🇸 FDA
Patent

US 12351839

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

granted A61PA61P31/00A61P31/04

Quick answer

US patent 12351839 (Rationally-designed single-chain meganucleases with non-palindromic recognition sequences) held by Precision BioSciences, Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P31/00, A61P31/04, A61P31/12, A61P33/02